Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88200209 |
LAW OFFICE ASSIGNED |
LAW OFFICE 114 |
MARK SECTION |
MARK |
NYBCE (see, http://uspto.report/TM/88200209/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
NYBCE |
OWNER SECTION (current) |
NAME |
New York Blood Center, Inc. |
MAILING ADDRESS |
310 East 67th Street |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10065 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
New York Blood Center, Inc. |
MAILING ADDRESS |
310 East 67th Street |
CITY |
New York |
STATE |
New York |
ZIP/POSTAL CODE |
10065 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Louis C. Cullman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
OCtrademarks@klgates.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
alexis.douglas@klgates.com; raquel.bacchus@klgates.com |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Louis C. Cullman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
OCtrademarks@klgates.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
alexis.douglas@klgates.com; raquel.bacchus@klgates.com |
DOCKET/REFERENCE NUMBER |
1958427 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
035 |
CURRENT IDENTIFICATION |
Providing independent review of clinical trials for business purposes |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
039 |
CURRENT IDENTIFICATION |
Storage of blood and stem cells; stem cell storage |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
040 |
CURRENT IDENTIFICATION |
Cryopreservation of human cells |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Medical laboratory, pharmaceutical research services and conducting pharmaceutical clinical trials for others; Medical laboratory services,
namely, cell processing services for use by others |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
044 |
CURRENT IDENTIFICATION |
Blood bank services; tissue bank services; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
product or service research or development |
ALLOWANCE MAIL DATE |
08/20/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
5 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
625 |
TOTAL AMOUNT |
625 |
SIGNATURE SECTION |
SIGNATURE |
/acd/ |
SIGNATORY'S NAME |
Alexis Crawford Douglas |
SIGNATORY'S POSITION |
Attorney of record, Illinois bar member |
DATE SIGNED |
08/20/2020 |
SIGNATORY'S PHONE NUMBER |
312-807-4346 |
FILING INFORMATION |
SUBMIT DATE |
Thu Aug 20 18:04:30 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XX.X-20
200820180430508110-882002
09-740264355ee76cc24cc161
d52cffdce3a8bc46ad83ddecf
b6f8b0d43bc3279293-DA-042
91222-2020082012422962927
1 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: NYBCE (see, http://uspto.report/TM/88200209/mark.png)
SERIAL NUMBER: 88200209
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: New York Blood Center, Inc., having an address of
310 East 67th Street
New York, New York 10065
United States
Proposed: New York Blood Center, Inc., having an address of
310 East 67th Street
New York, New York 10065
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 08/20/2019.
For International Class 035:
Current identification: Providing independent review of clinical trials for business purposes
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 039:
Current identification: Storage of blood and stem cells; stem cell storage
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 040:
Current identification: Cryopreservation of human cells
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Medical laboratory, pharmaceutical research services and conducting pharmaceutical clinical trials for others; Medical laboratory services, namely, cell processing services
for use by others
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 044:
Current identification: Blood bank services; tissue bank services; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development
Correspondence Information (current):
Louis C. Cullman
PRIMARY EMAIL FOR CORRESPONDENCE: OCtrademarks@klgates.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alexis.douglas@klgates.com; raquel.bacchus@klgates.com
Correspondence Information (proposed):
Louis C. Cullman
PRIMARY EMAIL FOR CORRESPONDENCE: OCtrademarks@klgates.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): alexis.douglas@klgates.com; raquel.bacchus@klgates.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $625 will be submitted with the form, representing payment for 5 classes.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /acd/ Date Signed: 08/20/2020
Signatory's Name: Alexis Crawford Douglas
Signatory's Position: Attorney of record, Illinois bar member
Signatory's Phone: 312-807-4346
RAM Sale Number: 88200209
RAM Accounting Date: 08/20/2020
Serial Number: 88200209
Internet Transmission Date: Thu Aug 20 18:04:30 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.X-20200820180430508
110-88200209-740264355ee76cc24cc161d52cf
fdce3a8bc46ad83ddecfb6f8b0d43bc3279293-D
A-04291222-20200820124229629271